• Latest Posts

Ablynx Launches $175M IPO on Wall Street After Phase III Success

More News! 23 Aug 2017

Dutch Biotech could treat Dyslipidemia with Belgian Nanobody

Sanofi Offers up to €2.4Bn to Belgian Biotech to Develop Nanobodies

Merck Outsources the Development of its Nanobody for Psoriasis

An Antibody to reduce Hospitalizations of Children starts Phase IIb trials

This company just turned the lights ON for NanoMed Bioplastic


Belgian Biotech Breaks New Ground in Fight Against Life-Threatening Blood Disorder

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

When Nanoparticles meet Virtual Tumours to build Oncology Platform

‘Cyborg’ Heart Patch to Revolutionize Treatment of Heart Attacks

French Nanomedicine Biotech Gets €21M to Kill Cancer with ‘Beam Rays’

Sperm Cells Enlisted as Nanobot Delivery Guys